Quotient Bioresearch signs agreement with Cambridge Research Biochemicals
Quotient Bioresearch provides early stage and specialist drug development services to pharmaceutical, biotechnology and medical device clients worldwide. Peptides which have been site-specifically labeled with tritium are ideal
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.